locally advanced/recurrent or metastatic gastric cancer
Conditions
Interventions
Based on the patient's tumor type, stage, and previous treatment history, participants will be enrolled into one of three different treatment regimen groups:None
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Signed informed consent and voluntarily participated. 2.Histologically or cytologically confirmed locally advanced, recurrent, or metastatic gastric cancer. 3.Aged >= 18 years. 4.Investigator-determined eligibility for relafenopride a therapy.
Exclusion criteria
Exclusion criteria: 1.Evidence of pregnancy or lactation in female patients. 2.Receiving treatment in a blinded trial. 3.Other ineligible conditions at the investigator’s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety analysis;real-world Progression-Free-Survival, rwPFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| duration of therapy;adverse events; | — |
Countries
China
Contacts
Public ContactLei Cong
Shandong Provincial Hospital
Outcome results
None listed